FierceBiotechFierceBiotechResearchFierceBiotechITFierceVaccinesFiercePharmaFiercePharmaManufacturing   FierceHealthcare
Related Topics >> Zogenix | Biotech Venture Capital

Zogenix - Top 20 VC deals of 2007

Tools

Company: Zogenix
Based: San Diego, CA
Amount: $78.8M
Investors: Abingworth Management, Clarus Ventures, Domain Associates, Scale Venture Partners, Thomas, McNerney & Partners, Undisclosed Investor

Scoop: Zogenix is developing CNS disorders and pain treatments. In December 2007 the company submitted an NDA for sumatriptan DosePro, a needle-free, disposable, subcutaneous delivery system for migraine. Zogenix is also working on a Phase III controlled release opioid product it in-licensed from Elan.

More News:
Zogenix gains $60M in new VC funds. Report
Zogenix raises $18M in preferred stock financing. Report


SHARE
WITH:
Email Twitter Facebook LinkedIn StumbleUpon
Get Your FREE FierceBiotech Email Newsletter:
Be the first to comment
More stories about Zogenix   Biotech Venture Capital  

Comments

Post new comment

The content of this field is kept private and will not be shown publicly.

More information about formatting options

To combat spam, please enter the code in the image.